NUTX · Nutex Health Inc.
$149.03
+0.33 (+0.22%)
At close · Jul 28
Market Cap
$1.03B
Shares
6.88M
Nutex Health Inc. Earnings Call Transcripts
Every quarterly earnings call for Nutex Health Inc. (NUTX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲19.7%
$67.45M
−$364,000
'24 Q1
24-05-09
▲29.1%
$76.08M
−$364,000
'24 Q2
24-08-08
▲25.6%
$78.80M
−$8.79M
'24 Q3
24-11-07
▲269.8%
$257.62M
$61.70M
'24 Q4
25-03-31
▲214%
$211.79M
$21.22M
'25 Q1
25-05-13
▲220.7%
$243.99M
−$17.70M
'25 Q2
25-08-14
▼41.1%
$151.68M
$11.83M
'25 Q4
26-03-05
LATEST
▲2.2%
$216.49M
$46.81M
'26 Q1
26-04-30
Earnings call
FY26 · Q1
2026-04-30
Nutex Health Inc. Q1 FY2026 Earnings Call
Confident tone
IPA / Population Health segment
IDR / payer reimbursement and No Surprises Act
Revenue and earnings performance
Revenue
$216.49M
▲ 2.2% YoY Diluted EPS
$6.52
▲ 95.8% YoY Gross margin
42.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-05
Nutex Health Inc. Q4 FY2025 Earnings Call
Confident tone
IDR arbitration and No Surprises Act
Hospital expansion pipeline
Revenue and earnings growth
Revenue
$151.68M*
▼ 41.1% YoY Gross margin
30.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q2
2025-08-14
Nutex Health Inc. Q2 FY2025 Earnings Call
Confident tone
No Surprises Act / IDR Arbitration Strategy
Financial Performance and Growth
Mature Hospital Performance and Patient Acuity
Revenue
$243.99M
▲ 220.7% YoY Diluted EPS
$-2.95
Gross margin
51.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
Nutex Health Inc. Q1 FY2025 Earnings Call
Confident tone
Balance sheet and capital allocation
Patient volume and acuity mix
Arbitration process and IDR revenue
Revenue
$211.79M
▲ 214% YoY Diluted EPS
$3.33
Gross margin
55.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-31
Nutex Health Inc. Q4 FY2024 Earnings Call
Confident tone
Arbitration / IDR process success
No Surprises Act challenges
Revenue and EBITDA growth
Revenue
$257.62M
▲ 269.8% YoY Diluted EPS
$11.12
Gross margin
55.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Nutex Health Inc. Q3 FY2024 Earnings Call
Confident tone
Revenue and patient volume growth
De novo hospital expansion pipeline
No Surprises Act and IDR reimbursement
Revenue
$78.80M
▲ 25.6% YoY Diluted EPS
$-1.72
Gross margin
27.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Nutex Health Inc. Q2 FY2024 Earnings Call
Confident tone
Population Health / IPAs
Micro-Hospital Business Model
No Surprises Act Arbitration
Revenue
$76.08M
▲ 29.1% YoY Diluted EPS
$-0.07
Gross margin
29.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Nutex Health Inc. Q1 FY2024 Earnings Call
Confident tone
No Surprises Act Collections & Reimbursement
Population Health / Medicare Advantage (MA) Lives
Earnings Growth & Financial Performance
Revenue
$67.45M
▲ 19.7% YoY Diluted EPS
$-0.08
Gross margin
15.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–8 of 8 earnings calls